Showing 15 posts of 32 posts found.

Pfizer to pay $345 million in EpiPen lawsuit

July 16, 2021
Medical Communications Mylan, Pfizer, epipen

Pfizer has reached a $345 million settlement over consumer claims they overpaid for EpiPens as a result of unfair, anticompetitive …


Teva launch generic version of EpiPen for children

August 21, 2019
Research and Development Mylan, Teva, allergies, children, epipen, pharma

A generic version of Mylan’s EpiPen, manufactured by Teva, is now available for children weighing between 15kg and 30kg in …


Novartis aims to solve EpiPen shortage with generic launch of Symjepi to US pharmacies

July 10, 2019
Manufacturing and Production, Research and Development, Sales and Marketing Mylan, Novartis, Sandoz, US, epipen, pharma

Novartis has announced the immediate availability of its generic epinephrine auto-injector in pharmacies throughout the US, as it moves to …


Teva’s EpiPen generic retails for same price as Mylan’s own

November 28, 2018
Research and Development, Sales and Marketing Mylan, Teva, epipen, pharma

Israeli generics firm Teva has revealed the price tag of its generic version of Mylan’s EpiPen epinephrine auto-injector, and, at …


MHRA to extend EpiPen expiry dates to tackle shortages

October 18, 2018
Manufacturing and Production, Sales and Marketing ALK+, Denmark, Mylan, UK, alk, epipen

The British government has extended the expiry date on epinephrine pens amid a shortage in the UK. The Danish pharmaceutical …


FDA approves first-ever generic EpiPen versions, courtesy of Teva

August 17, 2018
Medical Communications, Sales and Marketing FDA, Mylan, Teva, US, epipen, pharma

The FDA has announced the approval of the first generic versions of Mylan’s EpiPen and EpiPen Jr epinephrine auto-injectors as …


Top Ten most popular articles on Pharmafile.com this week

April 20, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, EMA, GW Pharma, J&J, JJ, MHRA, Mylan, Novartis, Sanofi, Shire, Takeda, biotech, drugs, epipen, keytruda, pharma, pharmaceutical

It’s the end of another week and there’s really been one story that has dominated the headlines – Takeda’s potential …


EpiPen shortage hits UK and Canada hard, but not US

April 18, 2018
Research and Development, Sales and Marketing Mylan, Pfizer, biotech, drugs, epipen, pharma, pharmaceutical

Manufacturing issues at the single Pfizer plant that produces the EpiPen epinephrine injector has caused serious shortages in the UK …


Mylan looks to muscle in on Allergan’s Botox territory

March 1, 2018
Sales and Marketing Botox, Mylan, Revance Therapeutics, biotech, drugs, epipen, pharma, pharmaceutical

Mylan announced, alongside its financials, that it had signed a global collaboration and licensing agreement with Revance Therapeutics to partner …


FDA unveils guidelines to help generic medical device versions reach the market

November 28, 2017
Research and Development, Sales and Marketing FDA, Mylan, Scott Gottlieb, auto injector, auto-injector, epipen, pharma

The scandal surrounding Mylan’s price-hiking of its flagship EpiPen epinephrine auto-injector was the news of last summer, continuing to grab …


Investors demand resignation of Mylan executives over pay packages

June 29, 2017
Sales and Marketing Heather Bresch, Mylan, epipen

As confidence in Mylan continues to fall and share prices plummet after last year’s EpiPen pricing scandal and subsequent PR …


New rival to EpiPen receives FDA approval to shake up market

June 16, 2017
Medical Communications, Sales and Marketing Adamis, Mylan, Symjepi, epipen

Adamis Pharmaceuticals has revealed that it received FDA approval for its EpiPen rival to enter the market. Its product, to …


Mylan overcharged for EpiPen by $1.7 billion, new report says

June 1, 2017
Sales and Marketing Mylan, epipen

More bad news for Mylan as a new report from the Department of Health and Human Services’ Office of the …


Study reveals EpiPens stay effective years after expiration date

May 10, 2017
Research and Development EpiPen expiration, Mylan, Mylan scandal, epipen

The Annals of Internal Medicine has published a study that indicated that EpiPen injectors retain a medically significant proportion of …


Sanofi launches lawsuit against Mylan over “illegal business practices”

April 26, 2017
Research and Development, Sales and Marketing Auvi-Q, Mylan, Sanofi, epipen, lawsuit

In a move that is sure to pile even more pressure onto Mylan after the company’s recent woes, Sanofi has …

Latest content